5th Microbiome Movement - Drug Development Summit

19/10/2020 - 21/10/2020
Boston,

The Microbiome Movement – Drug Development Summit (October 19-21, Boston MA) continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

With 70+ world class speakers, 3 days of unrivalled content, 2 deep dive workshops and 1 pre-conference oncology day, attendance will give you access to:

  1. More Clinical Case-Studies for Microbiome-Based Therapeutics
    With industry attention on demonstrating clinical efficacy and progress through human trials, listen to newly published clinical case-studies from Seres Therapeutics, Finch Therapeutics, Rebiotix, as well as clinician perspectives from Brigham & Women’s Hospital, Mayo Clinic and OpenBiome to give you expert insights from the trailblazers in the industry
  2. New Insights on Microbiome Biomarkers, Diagnostics and Drug Metabolism
    As the microbiome continues to demonstrate itself as a major factor in personalized medicine, this year’s discussion will continue to shine the spotlight on microbiome biomarkers as a tool to accurately diagnose and treat disease with case-studies from the Crohn’s & Colitis Foundation, DayTwo, Viome, Merck ESC and many more to share the most exciting area in microbiome research
  3. The Next Generation of Microbiome-Targeting Modalities & Drug Discovery Platforms
    With progress developing in microbial-derived small molecules, engineered microbes and subtractive platforms, hear from Kaleido Biosciences, Enterome, Novome Biotechnologies, BiomX and many more who continue to demonstrate new findings in therapeutic options outside of Live Biotherapeutics

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also to make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Find out more here: https://bit.ly/38Lqygu